<DOC>
	<DOCNO>NCT01084408</DOCNO>
	<brief_summary>The aim trial ass efficacy Paclitaxel-coated SeQuent®Please angioplasty balloon treatment stenoses native coronary artery compare drug elute stent .</brief_summary>
	<brief_title>Efficacy SeQuent®Please Treatment De-novo Stenoses Versus Taxus™Liberté™</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Age &gt; 18 year Clinical evidence stable unstable angina positive functional study Single , stenotic de novo lesion native coronary artery , type A select B1 ( see 4.3.1.1 Definition lesion type ) Diameter stenosis &gt; 70 % ( visual estimate ) Vessel diameter 2.5 3.5 mm Female patient enter study postmenopausal least two year undergone hysterectomy sterilization Signed patient inform consent form Patient 's treat physician 's agree patient return require post procedure followup assessment define clinical protocol Left ventricular ejection fraction &lt; 30 % Visible thrombus proximal lesion Expection treatment device PTCA require lesion . Stenosis within bypass graft Known hypersensitivity contraindication aspirin , heparin , clopidogrel , paclitaxel , sensitivity contrast medium adequately premedicated Other medical illness ( i.e . cancer , liver disease congestive heart failure ) may require cytostatic radiation therapy , cause subject noncompliant protocol , confound data interpretation associate limited lifeexpectancy ( i.e. , less two year ) . Acute myocardial infarction within past 72 hour intend treatment ( define : Q wave infarction total creatinine kinase ( CK ) &gt; 3 time upper normal limit , CK remain elevated hospital normal time treatment ) Chronic renal insufficiency serum creatinine &gt; 2.0 mg % Significant gastrointestinal ( GI ) bleed within past six month . History bleed diathesis coagulopathy refuse blood transfusion Extensive peripheral vascular disease precludes safe 6 French sheath insertion / require additional antiplatelet / anticoagulation treatment . Participating another device drug study within last 6 month may interfere interpretation result study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>de-novo</keyword>
	<keyword>coronary stenosis</keyword>
	<keyword>PEPCAD</keyword>
	<keyword>DEBonly</keyword>
	<keyword>Paclitaxel</keyword>
</DOC>